Table 4.
Maximum Correlations Using the Maximum Head and Neck Lymphedema and Fibrosis Symptom Inventory Scores with Established Self-Report Measure Score
Established measures | HN-LEF Symptom Inventory |
||||||
---|---|---|---|---|---|---|---|
Soft issues/neurologic toxicity | Systemic symptoms/social functioning | Jaw and oral dysfunction | Swallowing and taste changes | Body image and sexuality | Communication | Mucosal irritation | |
EORTC-QLQ Global Health | −0.25 | −0.52 | −0.27 | −0.33 | −0.34 | −0.38 | −0.49 |
Neck Disability Index | 0.48 | 0.66 | 0.35 | 0.39 | 0.43 | 0.51 | 0.52 |
Short-Form McGill Pain Questionnaire | |||||||
Sensory | 0.45 | 0.50 | 0.45 | 0.42 | 0.43 | 0.51 | 0.47 |
Affective | 0.47 | 0.62 | 0.49 | 0.38 | 0.44 | 0.47 | 0.50 |
Present pain intensity | 0.56 | 0.53 | 0.37 | 0.40 | 0.31 | 0.41 | 0.45 |
Visual analogue | 0.46 | 0.59 | 0.40 | 0.35 | 0.32 | 0.45 | 0.48 |
VHNSS | |||||||
Mouth pain | 0.34 | 0.30 | 0.40 | 0.40 | 0.42 | 0.43 | 0.37 |
General pain | 0.49 | 0.49 | 0.49 | 0.55 | 0.37 | 0.49 | 0.60 |
Swallowing solids | 0.40 | 0.51 | 0.43 | 0.56 | 0.39 | 0.45 | 0.42 |
Swallowing liquids | 0.27 | 0.44 | 0.41 | 0.53 | 0.36 | 0.33 | 0.47 |
Nutrition | 0.33 | 0.45 | 0.33 | 0.52 | 0.37 | 0.42 | 0.47 |
Mucus | 0.22 | 0.49 | 0.34 | 0.60 | 0.36 | 0.40 | 0.57 |
Dry mouth | 0.21 | 0.45 | 0.26 | 0.63 | 0.37 | 0.29 | 0.44 |
Taste/smell | 0.35 | 0.57 | 0.53 | 0.60 | 0.46 | 0.71 | 0.62 |
Voice/communication | 0.42 | 0.57 | 0.52 | 0.63 | 0.60 | 0.70 | 0.59 |
Teeth | 0.50 | 0.49 | 0.39 | 0.36 | 0.40 | 0.73 | 0.56 |
Hearing | 0.33 | 0.49 | 0.57 | 0.26 | 0.23 | 0.37 | 0.44 |
Trismus | 0.43 | 0.29 | 0.66 | 0.40 | 0.28 | 0.35 | 0.29 |
Neck range of motion | 0.48 | 0.36 | 0.56 | 0.38 | 0.49 | 0.26 | 0.23 |
Hospital Anxiety and Depression Scale | |||||||
Total | 0.36 | 0.62 | 0.40 | 0.40 | 0.52 | 0.46 | 0.57 |
Anxiety | 0.45 | 0.62 | 0.47 | 0.44 | 0.44 | 0.57 | 0.51 |
Depression | 0.46 | 0.65 | 0.43 | 0.49 | 0.54 | 0.47 | 0.53 |
VHNSS–GSS | |||||||
Unexplained fatigue | 0.46 | 0.63 | 0.38 | 0.42 | 0.35 | 0.52 | 0.50 |
Fatigue limits activity | 0.45 | 0.64 | 0.46 | 0.50 | 0.38 | 0.49 | 0.59 |
Falling asleep | 0.41 | 0.61 | 0.30 | 0.39 | 0.31 | 0.31 | 0.39 |
Staying asleep | 0.32 | 0.66 | 0.29 | 0.37 | 0.43 | 0.44 | 0.49 |
Unexplained sweating | 0.33 | 0.58 | 0.26 | 0.41 | 0.37 | 0.30 | 0.43 |
Cold | 0.25 | 0.50 | 0.32 | 0.52 | 0.36 | 0.33 | 0.36 |
Hot | 0.24 | 0.48 | 0.24 | 0.31 | 0.29 | 0.51 | 0.38 |
Memory | 0.46 | 0.43 | 0.35 | 0.28 | 0.28 | 0.42 | 0.44 |
Joint pain/aches | 0.34 | 0.51 | 0.28 | 0.42 | 0.47 | 0.40 | 0.40 |
Sad/depressed | 0.45 | 0.47 | 0.35 | 0.41 | 0.48 | 0.39 | 0.43 |
Anxious | 0.18 | 0.45 | 0.42 | 0.31 | 0.41 | 0.34 | 0.47 |
Marlowe–Crowne Social Desirability Scale—Short Form C | −0.25 | −0.23 | −0.05 | −0.21 | −0.37 | −0.19 | −0.25 |
Values in italics indicate at least 20% shared variability; values in bold indicate at least 30% shared variance.
Maximum observed correlation from the posttreatment assessment time points.
Highest single symptom (item) value comprising each HN-LEF Symptom Inventory subscale.